| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |